GlucoTrack Inc (GCTK)
2.44
-0.01
(-0.41%)
USD |
NASDAQ |
Sep 27, 16:00
GlucoTrack Enterprise Value: 13.41M for Sept. 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 27, 2024 | 13.41M |
| September 26, 2024 | 13.47M |
| September 25, 2024 | 13.25M |
| September 24, 2024 | 13.46M |
| September 23, 2024 | 13.30M |
| September 20, 2024 | 14.62M |
| September 19, 2024 | 16.04M |
| September 18, 2024 | 15.93M |
| September 17, 2024 | 16.04M |
| September 16, 2024 | 15.27M |
| September 13, 2024 | 15.99M |
| September 12, 2024 | 16.15M |
| September 11, 2024 | 15.52M |
| September 10, 2024 | 15.49M |
| September 09, 2024 | 15.08M |
| September 06, 2024 | 14.56M |
| September 05, 2024 | 14.56M |
| September 04, 2024 | 14.51M |
| September 03, 2024 | 14.23M |
| August 30, 2024 | 14.28M |
| August 29, 2024 | 14.59M |
| August 28, 2024 | 14.84M |
| August 27, 2024 | 14.89M |
| August 26, 2024 | 14.62M |
| August 23, 2024 | 14.84M |
| Date | Value |
|---|---|
| August 22, 2024 | 13.70M |
| August 21, 2024 | 13.52M |
| August 20, 2024 | 12.97M |
| August 19, 2024 | 12.92M |
| August 16, 2024 | 11.33M |
| August 15, 2024 | 11.00M |
| August 14, 2024 | 8.971M |
| August 13, 2024 | 8.091M |
| August 12, 2024 | 6.235M |
| August 09, 2024 | 5.577M |
| August 08, 2024 | 5.632M |
| August 07, 2024 | 6.016M |
| August 06, 2024 | 5.742M |
| August 05, 2024 | 7.166M |
| August 02, 2024 | 7.495M |
| August 01, 2024 | 7.276M |
| July 31, 2024 | 6.618M |
| July 30, 2024 | 7.056M |
| July 29, 2024 | 7.659M |
| July 26, 2024 | 7.495M |
| July 25, 2024 | 7.807M |
| July 24, 2024 | 7.768M |
| July 23, 2024 | 7.933M |
| July 22, 2024 | 7.818M |
| July 19, 2024 | 7.276M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.571M
Minimum
Sep 26 2023
120.51M
Maximum
Nov 01 2019
40.21M
Average
41.18M
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 556.40M |
| Retractable Technologies Inc | -17.59M |
| InfuSystems Holdings Inc | 177.90M |
| Xtant Medical Holdings Inc | 120.84M |
| Catheter Precision Inc | 1.844M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.489M |
| Total Expenses (Quarterly) | 4.491M |
| EPS Diluted (Quarterly) | -0.82 |
| Earnings Yield | -99.18% |
| Normalized Earnings Yield | -106.61 |